Cybin Inc

Lighting the way this Diwali towards a brighter future in mental health. May the festival of lights inspire us all to seek wellness and joy. 🪔✨ #Diwali #DiwaliWellness #LightOverDarkness

#Cybin CEO Doug Drysdale will be speaking at the 2024 Milken Institute Future of Health Summit on a panel entitled “The Next Frontier in Mental Health Research” on Wednesday, November 13, 2024, at 4:30 - 5:30 PM EST. “We share the Milken Institute’s inspiring commitment to accelerating medical research and improving health outcomes and are pleased to once again participate in this important event,” said Doug Drysdale, Chief Executive Officer of Cybin. Learn more: https://loom.ly/4r6Nng0 #MentalHealth #Biotechnology #Neuropsychiatry #MentalHealthResearch

Explore Cybin Inc's pioneering CYB005 program shaping the future of mental health treatments. Embracing innovation to transform CNS disorders, Cybin is at the forefront of biotech advancements. Witness the evolution and impact of this visionary company in mental health. "The granting of this patent in support of our CYB005 phenethylamines program reinforces our commitment to expanding the breadth of innovative development work beyond our clinical tryptamine programs," said Doug Drysdale, Chief Executive Officer of Cybin Inc. #Cybin #Innovation 💡

#Cybin is pleased to announce the grant of its first US composition of matter patent in support of its #CYB005 phenethylamines program evaluating non-hallucinogenic dosing of candidate molecules for the treatment of Central Nervous System (#CNS) disorders. “The granting of this patent in support of our CYB005 phenethylamines program reinforces our commitment to expanding the breadth of innovative development work beyond our clinical tryptamine programs,” said Cybin CEO Doug Drysdale “Non-hallucinogenic 5-HT receptor agonists have garnered a great deal of attention in recent years, and we are eager to continue exploring their clinical potential in CNS disorders." Learn more: https://loom.ly/4r6Nng0

It is easy to forget or overlook just how challenging it is for people to come out, to be their genuine selves among family, friends, and in the workplace. WE, the family, friends, and colleagues can play our part in making them feel safe, loved, and included. A small gesture goes a long way.

On #WorldMentalHealthDay, we reaffirm our commitment to revolutionizing mental healthcare. With innovative, science-driven therapies, we strive to make mental wellness accessible for all, providing hope for those battling depression, anxiety, and other mental health challenges. Together, we can change minds and transform lives. #WorldMentalHealthDay #MentalHealth

#Cybin CEO Doug Drysdale will participate in a Water Tower Research LLC fireside chat tomorrow, October 8, 2024, at 3:00 p.m. ET. to discuss our lead development programs, upcoming clinical milestones, and what differentiates our approach from other neuropsychiatric developments. Click here to register for the webcast: https://loom.ly/ZWbQva4 #MentalHealthInnovation #Biotechnology #Neuropsychiatry

During Depression Awareness Month, we at Cybin are focused on the potential of CYB003 to transform the treatment of major depressive disorder. Our dedication to innovative solutions is a beacon of hope for many. Join us in shining a light on mental health this October. #Depression #DepressionAwareness #Cybin #MentalHealth

#Cybin CEO Doug Drysdale will participate in a Water Tower Research LLC fireside chat next Tuesday, October 8, 2024, at 3:00 p.m. ET. to discuss our lead development programs, upcoming clinical milestones, and what differentiates our approach from other neuropsychiatric developments. Click here to register for the webcast: https://loom.ly/ZWbQva4 #MentalHealthInnovation #Biotechnology #Neuropsychiatry